Ventures

Four ventures. One founding question.

Every organization below exists to close a specific gap between what patients deserved and what the system was actually delivering.

Clinical practice

PRMA Plastic Surgery

PRMA is a national center of excellence in microsurgical breast reconstruction, based in San Antonio, Texas. We grew PRMA from a regional practice into one of the busiest breast reconstruction centers in the world, serving patients from across the United States and beyond.

The founding bet was depth over breadth: concentrating exclusively on the most complex, highest-quality procedures rather than general plastic surgery. The strategy was validated by volume, outcomes data, and a local and online referral network built entirely on clinical reputation.

PRMA's most important proof point is not volume. It is that the system delivers consistent outcomes independent of any individual surgeon in the room. That reproducibility was designed, not assumed.

PRMA Plastic Surgery →
Role
Joined 2006. Elected President 2017. Became CEO 2024.
Volume
15,000+ breast reconstructions performed.
Specialty
Microsurgical breast reconstruction. DIEP flap, thigh flaps, lymphedema surgery, sensory restoration after mastectomy (TruSense®).
Key publications
ASPS Evidence-Based Performance Measures for Autologous Breast Reconstruction (Plast Reconstr Surg, 2020). Practice-building template (Plast Reconstr Surg Glob Open, 2024).
Role
Head of Clinical Operations
Model
Physician-led platform. National hospital system partnerships.
Clinical focus
Reconstructive surgery, microsurgery, lymphedema, advanced nerve surgery, specialty programs.
Platform thesis
Evidence-based clinical pathways, outcomes measurement, and physician leadership extended across multiple markets without sacrificing autonomy or quality.
Clinical platform

Advanced Reconstructive Surgery Alliance (ARSA)

ARSA is a physician-led reconstructive surgery platform operating across multiple markets. I lead Clinical Operations with responsibility for clinical strategy, specialty program development, expansion of advanced reconstructive services, outcomes and quality standards, physician recruitment, and hospital system relationships.

The thesis is that what worked at PRMA (physician leadership, evidence-based pathways, outcomes-driven culture) can be extended nationally if the platform is built with clinical integrity at its core.

The Medical Leadership Board is the governance mechanism that ensures physician decision-making authority is preserved as the platform scales. Physician-led is not a marketing phrase at ARSA. It is a structural commitment.

Advanced Reconstructive Surgery Alliance →
Digital health / Toliman Health™

Breast Advocate®

Breast Advocate is the first shared decision-making app designed specifically for breast cancer surgery and reconstruction. It gives patients a structured, personalized way to understand every option available to them before they sit down with a surgeon.

The founding premise is that informed choice is the intervention. When patients make decisions that are fully informed and aligned with their own values, outcomes improve, decisional regret decreases, and the consultation becomes a different kind of conversation. Breast Advocate exists to create that starting point at scale.

Beyond consultation preparation, Breast Advocate provides 24/7 access to evidence-based, peer-reviewed patient education, so critical information is available throughout the patient journey, not just at a single decision point. A built-in community offers a safe space for patients to connect and share experiences along the way.

Breast Advocate is the flagship product of Toliman Health™, the digital health company I founded to deploy shared decision-making support infrastructure across specialties, health systems, and industry partners.

Download the Breast Advocate app →
Product
Free shared decision-making aid for iOS and Android. Decision wizard, option comparison, values clarification, and 24/7 access to evidence-based, peer-reviewed patient education. Consultation preparation tools and a peer support community for the full patient journey.
Parent company
Toliman Health™: patient-facing digital health platform for shared decision-making.
Clinical distinction
The only decision-support tool for breast cancer surgery and reconstruction that provides information on the full spectrum of surgical options, along with evidence-based, personalized treatment recommendations.
Published basis
Chrysopoulo, "The Importance of Shared Decision Making in Breast Reconstruction." Doximity Op-Med, 2017.
Clinical standard
Evidence-based approach to ingredient selection. No ingredient is included if it carries even a potentially harmful profile. Free of parabens, fragrance, and phthalates. Formulated to the safety threshold of a hormone-sensitive cancer patient.
Key ingredient
17% stabilized vitamin C. Significantly higher concentration than most products. Stabilized to prevent oxidation. (Oxidized vitamin C turns brown and is inactive.)
Origin
Developed as a post-reconstruction scar treatment. Adopted as a daily facial primer by patients long after recovery. Rebranded to reflect clinical-to-consumer evolution.
For
Cancer patients and survivors navigating recovery and long-term skin health.
Clinical skincare

InviCible Skincare™

InviCible was not designed for a consumer audience. It was designed for the most medically demanding use case: patients recovering from breast cancer treatment and reconstruction, with hormone-sensitive cancer in the picture and a bathroom cabinet full of products that were not built with their clinical reality in mind.

The survivorship care gap is real and documented. Patients completing treatment are left without adequate guidance on safe skincare. The wellness market fills that gap with anxiety rather than evidence. InviCible was built to provide the evidence-based alternative.

The market found the product before I went looking for a market. Patients used it long after their scars faded. It became a daily facial primer. That evolution showed that products built to the highest clinical standards, for the most demanding patient population, can perform well across a wider spectrum of use.

InviCible Skincare →
Stay in the loop

New writing, when it publishes.

One email when a new piece goes live. No newsletters, no noise.

Continue

Writing on physician leadership, patient advocacy, and clinical systems.

Read the writing →